Cipla Ltd (CIPLA) — Announcement | 27 August 2026(2 announcements)

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Cipla announces September 2026 investor meeting schedule
💡 Investor Takeaway
Investors can plan engagement with Cipla's management during these scheduled meetings.

Cipla announced its schedule for upcoming analyst and institutional investor meetings in September 2026, including in-person sessions with Jefferies in Gurgaon and Kotak in Mumbai, subject to change due to unforeseen circumstances.

2 Announcement 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Cipla completes restructuring of Aspergen Inc. via 100% stake acquisition by Indian JV
🔄 What Changed
Aspergen Inc. shifted from step-down subsidiary to wholly owned subsidiary of Aspergen Limited, India
💡 Investor Takeaway
The restructuring streamlines ownership without altering Cipla's stake in the US subsidiary.

Cipla announced a restructuring where Aspergen Limited, India acquired 100% of Aspergen Inc., USA from its subsidiaries, making the US entity a wholly owned subsidiary of the Indian JV. The move simplifies the group structure with no change to Cipla's economic stake in the US company, and the filing includes required SEBI disclosures.

About Cipla Ltd (CIPLA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,14,390.9 Cr P/E: 33.9 ROE: 9.8% ROCE: 13.2% Div Yield: 0.92%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

📊 More CIPLA filings

See all CIPLA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CIPLA — Free

Free account · 2 AI queries/day